Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: Risk factors for blindness and safety of observation

Neurosurgery

Volumn 59, Issue 5, 2006, Pages 1011-1017

  Cutler, Carolee M ^a   Lee, Janice S ^b   Butman, John A ^c   FitzGibbon, Edmond J ^d   Kelly, Marilyn H ^e   Brillante, Beth A ^e   Feuillan, Penelope ^f   Robey, Pamela G ^e   DuFresne, Craig R ^g   Collins, Michael T ^e  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL EYE INSTITUTE   (United States)

^e NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^f NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^g GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone; Gs ; GNAS; Growth hormone; McCune Albright syndrome

Indexed keywords

GROWTH HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLINDNESS; CHILD; COMPUTER ASSISTED TOMOGRAPHY; ENDOCRINE FUNCTION TEST; FEMALE; FIBROUS DYSPLASIA; GROWTH HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NERVE DECOMPRESSION; NEUROOPHTHALMOLOGY; OPTIC NERVE DISEASE; OPTIC NERVE ENCASEMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SAFETY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VISION; VISUAL DISORDER;

EID: 33845228439     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Akintoye SO, Chebli C, Booher S, Feuillan P, Kushner H, Leroith D, Cherman N, Bianco P, Wientroub S, Robey PG, Collins MT: Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab 87:5104-5112, 2002.
2. Akintoye SO, Kelly MH, Brillante B, Cherman N, Turner S, Butman JA, Robey PG, Collins MT: Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome. J Clin Endocrinol Metab 91:2960-2966, 2006.
3. Chen YR, Breidahl A, Chang CN: Optic nerve decompression in fibrous dysplasia: Indications, efficacy, and safety. Plast Reconstr Surg 99:22-33, 1997.
4. Collins MT, Shenker A: McCune-Albright syndrome: New insights. Curr Opin Endocrinol Diabetes 6:119-125, 1999.
5. Collins MT, Bianco P: Fibrous dysplasia, in Favus MJ (ed): Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Washington, D.C., American Society for Bone and Mineral Research, 2003, ed 5, pp 466-469.
6. Dorfman HD, Czerniak B: Fibro-osseous lesions, in Dorfman HD, Czerniak B (eds): Bone Tumors. St. Louis, Mosby, 1998, pp 441-491.
7. Edelstein C, Goldberg RA, Rubino G: Unilateral blindness after ipsilateral prophylactic transcranial optic canal decompression for fibrous dysplasia. Am J Ophthalmol 126:469-471, 1998.
8. Lee JS, FitzGibbon E, Butman JA, Dufresne CR, Kushner H, Wientroub S, Robey PG, Collins MT: Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med 347:1670-1676, 2002.
9. Michael CB, Lee AG, Patrinely JR, Stal S, Blacklock JB: Visual loss associated with fibrous dysplasia of the anterior skull base. Case report and review of the literature. J Neurosurg 92:350-354, 2000.
10. Moore AT, Buncic JR, Munro IR: Fibrous dysplasia of the orbit in childhood. Clinical features and management. Ophthalmology 92:12-20, 1985.
11. Papay FA, Morales L Jr, Flaharty P, Smith SJ, Anderson R, Walker JM, Hood RS, Hardy S: Optic nerve decompression in cranial base fibrous dysplasia. J Craniofac Surg 6:5-14, 1995.
12. Posnick J: Fibrous dysplasia of the craniomaxillofacial region: Current clinical perspectives. Br J Oral Maxillofac Surg 36:264-273, 1998.
13. Ricalde P, Horswell BB: Craniofacial fibrous dysplasia of the fronto-orbital region: Acase series and literature review. J Oral Maxillofac Surg 59:157-168, 2001.
14. Riminucci M, Collins MT, Jane JA, Lin KY: Craniofacial fibrous dysplasia, in Lin KY, Ogle RC, Jane JA (eds): Craniofacial Surgery. Philadelphia, W.B. Saunders, 2002, pp 366-381.
15. Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Robey PG, Bianco P: The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: Site-specific patterns and recurrent histological hallmarks. J Pathol 187:249-258, 1999.
16. Seiff SR: Optic nerve decompression in fibrous dysplasia: Indications, efficacy, and safety. Plast Reconstr Surg 100:1611-1612, 1997.
17. Shenker A, Chanson P, Weinstein LS, Chi P, Spiegel AM, Lomri A, Marie PJ: Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene. Hum Mol Genet 4:1675-1676, 1995.
18. Sherman SI, Ladenson PW: Octreotide therapy of growth hormone excess in the McCune-Albright syndrome. J Endocrinol Invest 15:185-190, 1992.
19. Uwaifo GI, Robey PG, Akintoye SO, Collins MT: Clinical picture: Fuel on the fire. Lancet 357:2011, 2001.